"serum-institute-of-india"

India’s proposed nationwide free HPV vaccination drive for girls aged 9 to 15 is significant, as its success could dramatically accelerate cervical cancer elimination targets globally

Vaccines have saved millions of lives and their benefits far outweigh the possible risks from the medical side-effects

AZ admitted that the vaccine developed with the University of Oxford to protect against COVID-19 may cause Thrombosis with Thrombocytopenia Syndrome (TTS) in “very rare cases”.

To date, the R21/Matrix-M malaria vaccine has been licensed for use in Ghana, Nigeria and Burkina Faso.

The company already has six million booster doses of Covovax vaccine available and adults must take the booster shot, said CEO Adar Poonawalla

Sangareddy: Union Minister of Education, Skill Development and Entrepreneurship Dharmendra Pradhan said that India is going to set play a vital role in Industrial Revolution 4.0 in the world. Unlike during the previous Industrial revolution when India was just a consuming nation, the union Minister said that India will become a producer nation. Addressing the […]

New Delhi: Serum Institute of India (SII) CEO Adar Poonawalla on Sunday wooed Elon Musk to invest in India to manufacture Tesla electric cars, saying it will be the best investment he would have ever made. Musk, who has made a successful USD 44 billion acquisition bid for Twitter, had in the past asked India […]

Pune: Eminent scientist and Executive Director of Serum Institute of India (SII) Dr Suresh S. Jadhav – who was instrumental in developing the lifesaver Covishield vaccine – passed away after a prolonged illness at a private hospital late on Tuesday night. He was 72 and is survived by his wife and two children. Jadhav’s demise […]

More than half of the adult population has yet to receive even a single dose, despite a slight improvement in coverage in July

As against 86 lakh doses that need to be administered per day, the vaccination rate has been just 40 lakh a day over the past week

The Centre must speed up negotiations with foreign companies towards the removal of stumbling blocks to expand coverage

"Excited to witness the first batch of Covovax (developed by @Novavax) being manufactured this week at our facility in Pune," he shared in a tweet on Friday.

These 44 crore doses of COVID-19 vaccines will be delivered by their makers between August and December 2021, the Union Health Ministry said.

As per BSE block deal data, Poonawalla sold 31,57,034 scrips he held in the firm at a price of Rs 373.85 per share.

Task Force also discussed with them various alternatives to drugs that are in high demand like Remdesivir

India rolled out the third phase of its COVID-19 vaccination drive for those in the age group of 18-45 years on Saturday.

A million doses from the institute, which had already been delivered, have been sold on to other countries in the African Union.

Covovax trials finally begin in India; the vaccine is made through a partnership with Novavax and Serum Institute of India. It has been tested against African and UK variants of COVID19 and has an overall efficacy of 89 per cent.

Thailand last week was the first country outside Europe to temporarily suspend using the AstraZeneca vaccine.

Both SII and Bharat Biotech are involved in producing Covid-19 vaccine